日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2020-11-21 | 09:20-09:30 | B2鹭江厅 |
玻璃体视网膜疾病第三单元:糖尿病性视网膜病变 |
讲者 | Simultaneous Neutralization of Angiopoietin-2 (Ang-2) and Vascular Endothelial Growth Factor-A (VEGF-A) With Faricimab: A Review of the Phase 2 Clinical Trials in Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) |